News News

Cancer Care: Centre for the Investigation of Neuroendocrine Tumours – Castelfran-co Veneto

State-of-the-art integrated services boosts the range of diagnostic services provided.

Another Medipass success announced: the company helps its customers reach important developments. Clinical trials with 6/8Ga-Dotanoc tracer in PET/TC scans are now possible both in Rome and at the hospital in Castelfranco Veneto.

(16-05-2011 - Asca)
All rights reserved.